US9174881089
US9174881089
Utah Medical Products, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 236.58M EUR | 219.55M EUR | 197.38M EUR | 178.3M EUR |
Enterprise Value | 147.87M EUR | 132.22M EUR | 110.18M EUR | 92.77M EUR |
Valuation Multiples | ||||
Trailing P/E | 22.52x | 20.94x | 18.19x | 21.63x |
Forward P/E | -- | -- | -- | -- |
Price to Sales | 6.55x | 6.08x | 5.26x | 6.19x |
Price to Book | 1.94x | 1.8x | 1.64x | 1.49x |
EV/Revenue | 4.1x | 3.66x | 2.94x | 3.22x |
EV/EBITDA | 10.29x | 9.72x | 7.51x | 8.81x |
Price to FCF (P/FCF) | 26.77x | 19.18x | 15.16x | 17.76x |
EV/FCF | 16.73x | 11.55x | 8.46x | 9.24x |
FCF Yield | 3.74% | 5.21% | 6.6% | 5.63% |